TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...

TransMedics (NASDAQ ... Transporters use oxygenated perfusion at low temperatures, however, do not fully mimic physiological conditions. The TransMedics Organ Care System, OCS is a revolutionary ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

paints a grim picture of TransMedics' business practices. The report's allegations center on the company's warm perfusion technology platform, known as the Organ Care System (OCS), and its ...

BURLINGAME, CA, UNITED STATES, January 14, 2025 /EINPresswire / -- The Perfusion System Market Report is the result of extensive research and analysis conducted by our team of experienced market ...